-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
Fluphenazine dihydrochloride
Category | SARS-CoV |
CAS | 146-56-5 |
Description | Fluphenazine DiHCl is the dihydrochloride salt preparation of Fluphenazine. It has been used to deliver Fluphenazine to biological systems in studies probing the effects and metabolic fates of this commonly used dopamine antagonist. |
Product Information
Synonyms | Fluphenazine dihydrochloride;Fluphenazine hydrochloride;146-56-5;Prolixin;Anatensol;Permitil;Fluphenazine (dihydrochloride);FLUPHENAZINE HCL;Tensofin;Dapotum;Moditen;Squibb 4918;Calmansial;Fluphenazine chloride;OMCA;Flufenazin;Lyorodin;Liogen;Fluorophenazine dihydrochloride;CCRIS 4032;UNII-ZOU145W1XL;EINECS 205-674-1;ZOU145W1XL;NSC 179197;NSC-179197;1-(2-Hydroxyethyl)-4-(3-(2-trifluoromethyl-10-phenothiazinylpropyl)piperazine dihydrochloride;1-Piperazineethanol, 4-(3-(2-(trifluoromethyl)-10H-phenothiazin-10-yl)propyl)-, dihydrochloride;DTXSID00892922;Fluphenazine.2HCl;4-(3-(2-(Trifluoromethyl)phenothiazin-10-yl)propyl)-1-piperazineethanol dihydrochloride;Trancin;A 4077;Fluphenazine hydrochloride [USP:BAN:JAN];Permitil hydrochloride;10-(3-(4-(2-Hydroxyethyl)piperazinyl)propyl)-2-trifluoromethylphenothiazine dihydrochloride;4-[3-[2-(Trifluoromethyl)phenothiazin-10-yl]propyl]-1-piperazineethanol dihydrochloride;Fluphenazine DiHCl;1-piperazineethanol, 4-[3-[2-(trifluoromethyl)-10H-phenothiazin-10-yl]propyl]-, dihydrochloride;FLUPHENAZINE HYDROCHLORIDE (MART.);FLUPHENAZINE HYDROCHLORIDE [MART.];FLUPHENAZINE HYDROCHLORIDE (USP-RS);Fluphenazine hydrochloride (USP:BAN:JAN);FLUPHENAZINE HYDROCHLORIDE [USP-RS];NSC 62323;NSC179197;FLUPHENAZINE HYDROCHLORIDE (USP IMPURITY);FLUPHENAZINE HYDROCHLORIDE [USP IMPURITY];FLUPHENAZINE HYDROCHLORIDE (USP MONOGRAPH);FLUPHENAZINE HYDROCHLORIDE [USP MONOGRAPH];SR-01000003048;Siqualone;Fluphenazine 2HCl;Prolixin (TN);Prestwick_225;Fluphenazini hydrochloridum;Hydrochloride, Fluphenazine;4-[3-[2-(Trifluoromethyl)-10H-phenothiazin-10-yl]propyl]-1-piperazineethanol dihydrochloride;SCHEMBL41634;SPECTRUM1500994;CHEBI:5126;FLUFENAZINE HYDROCHLORIDE;CHEMBL1448187;DTXCID401284964;HMS1568P22;HMS1921O14;BCP18079;HY-A0081;Tox21_500555;MFCD00055212;s4569;Fluphenazine hydrochloride (JAN/USP);AKOS015960787;CCG-212902;CS-4290;LP00555;1-Piperazineethanol, 4-(3-(2-(trifluoromethyl)phenothiazin-10-yl)propyl)-, dihydrochloride;2-[4-[3-[2-(trifluoromethyl)phenothiazin-10-yl]propyl]piperazin-1-yl]ethanol;dihydrochloride;FLUPHENAZINE HYDROCHLORIDE [JAN];FLUPHENAZINE DIHYDROCHLORIDE [MI];NCGC00093941-01;NCGC00093941-02;NCGC00093941-03;NCGC00261240-01;AC-12201;BS-15804;DA-63493;FLUPHENAZINE HYDROCHLORIDE [VANDF];S4569 Fluphenazine (dihydrochloride).cd;FLUPHENAZINE HYDROCHLORIDE [WHO-DD];FLUPHENAZINE HYDROCHLORIDE [WHO-IP];EU-0100555;F1240;NS00079264;C72785;D00791;F 4765;FLUPHENAZINE HYDROCHLORIDE [ORANGE BOOK];FLUPHENAZINI HYDROCHLORIDUM [WHO-IP LATIN];SR-01000003048-2;SR-01000003048-9;W-108125;Fluphenazine.2HCl, 1mg/ml in Methanol (as free base);Q27295826;Z1592690505;Fluphenazine Dihydrochloride 1.0 mg/ml in Methanol (as free base);Fluphenazine dihydrochloride, European Pharmacopoeia (EP) Reference Standard;Fluphenazine Hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material;Fluphenazine hydrochloride, United States Pharmacopeia (USP) Reference Standard;2-(4-(3-(2-(Trifluoromethyl)-10H-phenothiazin-10-yl)propyl)piperazin-1-yl)ethanol dihydrochloride;2-(4-(3-(2-(Trifluoromethyl)-10H-phenothiazin-10-yl)propyl)piperazin-1-yl)ethanoldihydrochloride;2-(4-{3-[2-(Trifluoromethyl)-10H-phenothiazin-10-yl]propyl}-1-piperazinyl)ethanol dihydrochloride;2-[4-[3-[2-(trifluoromethyl)phenothiazin-10-yl]propyl]piperazin-1-yl]ethanol,dihydrochloride; |
IUPAC Name | 2-[4-[3-[2-(trifluoromethyl)phenothiazin-10-yl]propyl]piperazin-1-yl]ethanol;dihydrochloride |
Molecular Weight | 510.44 |
Molecular Formula | C22H28Cl2F3N3OS |
Canonical SMILES | OCCN1CCN(CCCN2C3=C(C=CC=C3)SC4=CC=C(C(F)(F)F)C=C24)CC1.[H]Cl.[H]Cl |
InChI | InChI=1S/C22H26F3N3OS.2ClH/c23-22(24,25)17-6-7-21-19(16-17)28(18-4-1-2-5-20(18)30-21)9-3-8-26-10-12-27(13-11-26)14-15-29;;/h1-2,4-7,16,29H,3,8-15H2;2*1H |
InChIKey | MBHNWCYEGXQEIT-UHFFFAOYSA-N |
Melting Point | 235-237 °C |
Purity | > 95% |
Solubility | Soluble to 38mg/mL in DMSO |
Appearance | White to Off-White Solid |
Shelf Life | 2 years |
Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |